{"name":"Hamad Medical Corporation","slug":"hamad-medical-corporation","ticker":"","exchange":"","domain":"hamadmedicalcorporation.com","description":"","hq":"Doha","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":6,"colorKey":"cardiovascular","drugs":[{"name":"Bivalirudin Injection","genericName":"Bivalirudin Injection","slug":"bivalirudin-injection","indication":"Other","status":"marketed"},{"name":"Diclofenac and Paracetamol","genericName":"Diclofenac and Paracetamol","slug":"diclofenac-and-paracetamol","indication":"Other","status":"marketed"},{"name":"Fairhaven Pro for men","genericName":"Fairhaven Pro for men","slug":"fairhaven-pro-for-men","indication":"Other","status":"marketed"},{"name":"Nebulized Lidocaine","genericName":"Nebulized Lidocaine","slug":"nebulized-lidocaine","indication":"Other","status":"marketed"},{"name":"Treatment 1. Metoclopramide","genericName":"Treatment 1. Metoclopramide","slug":"treatment-1-metoclopramide","indication":"Other","status":"marketed"},{"name":"Treatment 2 Ondansetron","genericName":"Treatment 2 Ondansetron","slug":"treatment-2-ondansetron","indication":"Prevention of nausea and vomiting induced by chemotherapy","status":"marketed"}]},{"name":"Neuroscience","slug":"neuroscience","revenue":0,"percentOfTotal":0,"drugCount":5,"colorKey":"neuroscience","drugs":[{"name":"Buccal midazolam","genericName":"Buccal midazolam","slug":"buccal-midazolam","indication":"Acute seizure management, particularly in pediatric patients","status":"marketed"},{"name":"Hi-dose iv MgSO4","genericName":"Hi-dose iv MgSO4","slug":"hi-dose-iv-mgso4","indication":"Neuroprotection in acute ischemic stroke","status":"phase_3"},{"name":"Intramuscular midazolam","genericName":"Intramuscular midazolam","slug":"intramuscular-midazolam","indication":"Acute anxiety and agitation","status":"marketed"},{"name":"Intranasal Midazolam","genericName":"Intranasal Midazolam","slug":"intranasal-midazolam","indication":"Acute seizure management","status":"marketed"},{"name":"Std-dose iv MgSO4","genericName":"Std-dose iv MgSO4","slug":"std-dose-iv-mgso4","indication":"Pre-eclampsia prevention and treatment","status":"phase_3"}]},{"name":"Immunology","slug":"immunology","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"oncology","drugs":[{"name":"Anti TNF + Meth","genericName":"Anti TNF + Meth","slug":"anti-tnf-meth","indication":"Rheumatoid arthritis","status":"phase_3"},{"name":"Dexamethasone Oral","genericName":"Dexamethasone Oral","slug":"dexamethasone-oral","indication":"Inflammatory and autoimmune disorders (rheumatoid arthritis, systemic lupus erythematosus)","status":"marketed"},{"name":"Pred + Meth","genericName":"Pred + Meth","slug":"pred-meth","indication":"Autoimmune and inflammatory disorders (specific indication not publicly detailed for this Phase 3 trial)","status":"phase_3"}]},{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"immunology","drugs":[{"name":"(TauroLock Hep500)","genericName":"(TauroLock Hep500)","slug":"taurolock-hep500","indication":"Prevention of catheter-related bloodstream infections (CRBSI) in patients with central venous catheters","status":"marketed"},{"name":"Homologous Blood Transfusion","genericName":"Homologous Blood Transfusion","slug":"homologous-blood-transfusion","indication":"Acute blood loss requiring volume and oxygen-carrying capacity restoration","status":"phase_3"}]},{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"infectious","drugs":[{"name":"Ceftolozane-tazobactam IV","genericName":"Ceftolozane-tazobactam IV","slug":"ceftolozane-tazobactam-iv","indication":"Complicated urinary tract infections (cUTI) including pyelonephritis","status":"marketed"},{"name":"TauroLock U 25000","genericName":"TauroLock U 25000","slug":"taurolock-u-25000","indication":"Prevention of catheter-related bloodstream infections in patients with central venous catheters","status":"marketed"}]},{"name":"Pain","slug":"pain","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"rare","drugs":[{"name":"Levobupivacaine and Fentanyl","genericName":"Levobupivacaine and Fentanyl","slug":"levobupivacaine-and-fentanyl","indication":"Local and regional anesthesia with analgesia","status":"marketed"},{"name":"Nebulized Fentanyl","genericName":"Nebulized Fentanyl","slug":"nebulized-fentanyl","indication":"Acute pain management","status":"phase_3"}]},{"name":"Hematology","slug":"hematology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"respiratory","drugs":[{"name":"Human albumin","genericName":"Human albumin","slug":"human-albumin","indication":"Hypovolemic shock and acute blood loss","status":"marketed"}]},{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"metabolic","drugs":[{"name":"Pioglitazone Plus dapaglifliozin","genericName":"Pioglitazone Plus dapaglifliozin","slug":"pioglitazone-plus-dapaglifliozin","indication":"Type 2 diabetes","status":"phase_3"}]}],"pipeline":[{"name":"Anti TNF + Meth","genericName":"Anti TNF + Meth","slug":"anti-tnf-meth","phase":"phase_3","mechanism":"This combination therapy blocks tumor necrosis factor (TNF) to suppress inflammatory immune responses while methotrexate inhibits dihydrofolate reductase to reduce cell proliferation and immune activation.","indications":["Rheumatoid arthritis","Other TNF-responsive inflammatory conditions"],"catalyst":""},{"name":"(TauroLock Hep500)","genericName":"(TauroLock Hep500)","slug":"taurolock-hep500","phase":"marketed","mechanism":"TauroLock Hep500 is a catheter lock solution that prevents bacterial biofilm formation and thrombosis in central venous catheters through a combination of taurolidine and heparin.","indications":["Prevention of catheter-related bloodstream infections (CRBSI) in patients with central venous catheters","Prevention of catheter thrombosis in central venous catheters"],"catalyst":""},{"name":"Bivalirudin Injection","genericName":"Bivalirudin Injection","slug":"bivalirudin-injection","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Buccal midazolam","genericName":"Buccal midazolam","slug":"buccal-midazolam","phase":"marketed","mechanism":"Buccal midazolam is a benzodiazepine that enhances inhibitory GABAergic neurotransmission in the central nervous system to produce sedation and anxiolysis.","indications":["Acute seizure management, particularly in pediatric patients","Pre-procedural sedation and anxiolysis","Acute agitation and anxiety"],"catalyst":""},{"name":"Ceftolozane-tazobactam IV","genericName":"Ceftolozane-tazobactam IV","slug":"ceftolozane-tazobactam-iv","phase":"marketed","mechanism":"Ceftolozane-tazobactam is a beta-lactam antibiotic combined with a beta-lactamase inhibitor that kills bacteria by inhibiting cell wall synthesis while protecting against enzymatic degradation.","indications":["Complicated urinary tract infections (cUTI) including pyelonephritis","Hospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia (VABP)","Complicated intra-abdominal infections (cIAI)"],"catalyst":""},{"name":"Dexamethasone Oral","genericName":"Dexamethasone Oral","slug":"dexamethasone-oral","phase":"marketed","mechanism":"Dexamethasone is a synthetic glucocorticoid that suppresses the immune system and reduces inflammation by binding to glucocorticoid receptors in the cytoplasm.","indications":["Inflammatory and autoimmune disorders (rheumatoid arthritis, systemic lupus erythematosus)","Allergic reactions and angioedema","Cerebral edema and increased intracranial pressure","Adrenocortical insufficiency","Certain malignancies (as adjunctive therapy)"],"catalyst":""},{"name":"Diclofenac and Paracetamol","genericName":"Diclofenac and Paracetamol","slug":"diclofenac-and-paracetamol","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Fairhaven Pro for men","genericName":"Fairhaven Pro for men","slug":"fairhaven-pro-for-men","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Hi-dose iv MgSO4","genericName":"Hi-dose iv MgSO4","slug":"hi-dose-iv-mgso4","phase":"phase_3","mechanism":"High-dose intravenous magnesium sulfate acts as a neuroprotective agent and anticonvulsant by blocking N-methyl-D-aspartate (NMDA) receptors and stabilizing neuronal membranes.","indications":["Neuroprotection in acute ischemic stroke","Seizure prophylaxis in eclampsia/preeclampsia","Traumatic brain injury neuroprotection"],"catalyst":""},{"name":"Homologous Blood Transfusion","genericName":"Homologous Blood Transfusion","slug":"homologous-blood-transfusion","phase":"phase_3","mechanism":"Homologous blood transfusion replaces lost or deficient blood volume and cellular components to restore oxygen-carrying capacity and hemostatic function.","indications":["Acute blood loss requiring volume and oxygen-carrying capacity restoration","Severe anemia","Coagulation disorders or thrombocytopenia requiring hemostatic support"],"catalyst":""},{"name":"Human albumin","genericName":"Human albumin","slug":"human-albumin","phase":"marketed","mechanism":"Human albumin acts as a plasma volume expander and carrier protein that restores intravascular oncotic pressure and transports endogenous and exogenous substances throughout the body.","indications":["Hypovolemic shock and acute blood loss","Severe hypoproteinemia and malnutrition","Burn management and fluid resuscitation","Liver cirrhosis with ascites","Nephrotic syndrome"],"catalyst":""},{"name":"Intramuscular midazolam","genericName":"Intramuscular midazolam","slug":"intramuscular-midazolam","phase":"marketed","mechanism":"Midazolam is a benzodiazepine that enhances the inhibitory effects of GABA at GABA-A receptors in the central nervous system, producing sedation, anxiolysis, and muscle relaxation.","indications":["Acute anxiety and agitation","Preoperative sedation and anxiolysis","Acute seizure management","Sedation in critical care settings"],"catalyst":""},{"name":"Intranasal Midazolam","genericName":"Intranasal Midazolam","slug":"intranasal-midazolam","phase":"marketed","mechanism":"Midazolam is a benzodiazepine that enhances the inhibitory effects of GABA at GABA-A receptors in the central nervous system, producing sedation and anxiolysis.","indications":["Acute seizure management","Acute anxiety and agitation","Procedural sedation"],"catalyst":""},{"name":"Levobupivacaine and Fentanyl","genericName":"Levobupivacaine and Fentanyl","slug":"levobupivacaine-and-fentanyl","phase":"marketed","mechanism":"Levobupivacaine blocks sodium channels to provide local anesthesia, while fentanyl activates opioid receptors to provide analgesia.","indications":["Local and regional anesthesia with analgesia"],"catalyst":""},{"name":"Nebulized Fentanyl","genericName":"Nebulized Fentanyl","slug":"nebulized-fentanyl","phase":"phase_3","mechanism":"Nebulized fentanyl is an inhaled opioid agonist that binds to mu opioid receptors in the central nervous system to provide rapid analgesia and sedation.","indications":["Acute pain management","Procedural sedation and analgesia"],"catalyst":""},{"name":"Nebulized Lidocaine","genericName":"Nebulized Lidocaine","slug":"nebulized-lidocaine","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Pioglitazone Plus dapaglifliozin","genericName":"Pioglitazone Plus dapaglifliozin","slug":"pioglitazone-plus-dapaglifliozin","phase":"phase_3","mechanism":"Pioglitazone is a thiazolidinedione that activates PPAR-γ, increasing insulin sensitivity, while dapagliflozin is an SGLT2 inhibitor that reduces glucose reabsorption in the kidneys.","indications":["Type 2 diabetes","Adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes"],"catalyst":""},{"name":"Pred + Meth","genericName":"Pred + Meth","slug":"pred-meth","phase":"phase_3","mechanism":"A combination of prednisolone (a corticosteroid) and methotrexate (an immunosuppressant/antimetabolite) that suppresses inflammation and immune activity.","indications":["Autoimmune and inflammatory disorders (specific indication not publicly detailed for this Phase 3 trial)"],"catalyst":""},{"name":"Std-dose iv MgSO4","genericName":"Std-dose iv MgSO4","slug":"std-dose-iv-mgso4","phase":"phase_3","mechanism":"Magnesium sulfate acts as an anticonvulsant and vasodilator by inhibiting neuronal excitability and promoting blood vessel dilation.","indications":["Pre-eclampsia prevention and treatment","Seizure prophylaxis in eclampsia"],"catalyst":""},{"name":"TauroLock U 25000","genericName":"TauroLock U 25000","slug":"taurolock-u-25000","phase":"marketed","mechanism":"TauroLock U 25000 is an antimicrobial lock solution that prevents biofilm formation and catheter-related bloodstream infections by combining taurolidine with heparin and uracil.","indications":["Prevention of catheter-related bloodstream infections in patients with central venous catheters","Maintenance of central venous catheter patency"],"catalyst":""},{"name":"Treatment 1. Metoclopramide","genericName":"Treatment 1. Metoclopramide","slug":"treatment-1-metoclopramide","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Treatment 2 Ondansetron","genericName":"Treatment 2 Ondansetron","slug":"treatment-2-ondansetron","phase":"marketed","mechanism":"Ondansetron blocks serotonin (5-HT3) receptors on chemoreceptor trigger zone and vagal afferent nerves to prevent nausea and vomiting.","indications":["Prevention of nausea and vomiting induced by chemotherapy","Prevention of post-operative nausea and vomiting","Prevention of radiation-induced nausea and vomiting"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxQYktoQ3ZIN0VEY2tVekFBVWVlX1Ytbk4tR1FwcnFfUWJGaHo2NnEtT2Zfc1NqSFdvd3pWd3drLWZEdkdmd3RKWXVHSzA2NXpHa2NKczZsTWQ4M2hLX2s0bW9NWTRWc1ZXci01anlUakJsd05uV0s3X2ZHaGpxUEFLdkxjakMwVEp4MHpzckQ3czBCUzJzRndrTVhYQXlHX2o2MU5sLW5HdFpzQdIBrwFBVV95cUxOTVhLMzd1UThWSGQ1Z2lQLW0xSVdfSk9WcWQtaS1hRXpvX29vTFJsblozelY3RDRsN1NSb2NpcTFxRnZLa2hSTnk4RklSLWQ0MjFGc1hRVzVOU0xoU1h2RnVlVWRqQnJHWmxmNWM5QllTWFp0NVEwUUVUNjhLSXFIT0hYcjJPNVlGSHlOZ0twUFE0NjBMdm5TeGVMSURoRmpyUmpTbTlkQ052WldKcUhF?oc=5","date":"2026-03-10","type":"pipeline","source":"Gulf Times","summary":"Qatar’s pharma industry powers through regional uncertainty| Gulf Times - Gulf Times","headline":"Qatar’s pharma industry powers through regional uncertainty| Gulf Times","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-12-10","type":"pipeline","source":"Qatar Tribune","summary":"HMC inks pact with int’l pharmaceutical firm to boost clinical research - Qatar Tribune","headline":"HMC inks pact with int’l pharmaceutical firm to boost clinical research","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxOQlN1T0FxdDhkSE5Hc1ZKQ0hYeDdyMWlSUG03Ry1JR2tURWJaOXowRjN0WkMxaWdZX0g0MUFHTnlFeHhDTUVSakFadVcyX01ZV2ptYVdqSUhrMkg2RDB1SGg0VUZ1SzI5M2p6NHlPSnVwaVhwam1uRUswellmaXVGa3d6clE?oc=5","date":"2025-10-23","type":"pipeline","source":"Forbes Middle East","summary":"Top Healthcare Leaders 2025 The Executives - Forbes Middle East","headline":"Top Healthcare Leaders 2025 The Executives","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxPT2VhZjhHNVpwVnBtQlM3VG11ZV9Rd2k3dVNxZ0FfMkluQjBWS0dKQWpPMVlQYlJ4aGppNWRnNnFEdlp1NmprbXVWWUNxUU5UR1Q1cmxoTTBBY1lsdUR3WEJ6anRZZDZVNmpESEhSRlg0TzdocmpWRlJZOGNyWEpaMFJ5dmphdVdlQVNyQVF2VVd2M3NCSDV0Vlp6amFsdGxyYlh5SUN5NzVMMU12cWM5UGhsQzhIbHpCWTF6Q1QtWkk0Zw?oc=5","date":"2025-10-22","type":"pipeline","source":"ILoveQatar.net","summary":"10 leaders from Qatar named in Forbes Middle East’s Top Healthcare Leaders 2025 (Executives & Founders) - ILoveQatar.net","headline":"10 leaders from Qatar named in Forbes Middle East’s Top Healthcare Leaders 2025 (Executives & Founders)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwJBVV95cUxQMEc0LUM5SldNS2xzb2lEcnl1WFNlY01KUm1pRWRaeXgtZlprb09CSDJKMUFGejNSb3FGWENmYVNuM2gxUm9rUFlRak9sandzWnpHTmNMcVFHZkdQcTB5bHFURU82VzBscXBkT0I3eDFiZFdBd1JVejZPazc4VXB4UkJfZzN3Rkl6NWhEZjlLTlFMam9XZXFyd3J0QlY3ZmIzczJOLURZVFFxdjNfMDZ6Z0F3ZTVqU1pSZ0ZzaFNPRGEtNVlraXdtNUdJLVJrSHlTa3BtYzRsVS1CT2gwZ0xxTkVFUFdrODVPRlltRzRUbVFWRldmRHJ5cXVHYTJ1NGxfQXR1TDBtbw?oc=5","date":"2025-10-20","type":"pipeline","source":"ZAWYA","summary":"Forbes Middle East reveals the Region’s Top Healthcare Leaders 2025, Founders & Shareholders and Executives lists - ZAWYA","headline":"Forbes Middle East reveals the Region’s Top Healthcare Leaders 2025, Founders & Shareholders and Executives lists","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxQRXIyLVUzazMtVGlvUWdZbVRCZEZkdUJNM1I1T3p2OU0tbDFOQkljR1ZEcTRmNkhoSUFPVGxSY2NHUnhTR25UbnpwcnJ3TnpVNjd3U0NlZE5BdEx1NzB5QU9VNU5XeUQtTGJIMk9fMF8xR2hOMUZabmlJalBSRFFWVWFR?oc=5","date":"2023-05-31","type":"pipeline","source":"China Daily - Global Edition","summary":"Bahrain's ambassador to China presents Prince Salman bin Hamad Medal of Medical Merit to Sinopharm - China Daily - Global Edition","headline":"Bahrain's ambassador to China presents Prince Salman bin Hamad Medal of Medical Merit to Sinopharm - China Daily","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxNaDdEWVVzSWNrNXM2NUUtT2ZjUGVNcDJGbU5BWEg0MnY2S3dqZk5EbkRVVlJzWGFnSUxQU01yWTZhZjJfMElvX2hEYXlNZE01aWcwamtxWjdjQTA2VDhoT2JEaHFiNF9rSkY0Z2hvUEFaanFRcDNCMENxN2xfbWRyVjlGTm1lU0hNWVBQeWtSeWZsdzhtdFJ1YVhPTDBYMTFiTGVLRzBUYmk?oc=5","date":"2022-04-08","type":"pipeline","source":"Forbes Middle East","summary":"Meet The Region's Top 50 Healthcare Leaders - Forbes Middle East","headline":"Meet The Region's Top 50 Healthcare Leaders","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxQb0tUZjRJY2hEREVCOUV1b1R3dEFaOFA0WDdtY1FiSnZtY2dDTnY5U2x4d3VfOWtkeEVRVGpTLUpUeXRPaWdvSmlpQkJXTWRzeTdQRi14cnN4QjJtQmVzamRCS0UxcFZvSEkyT1RKVzRVNEFnbktKSk1ITEhLQVYxQ2JEWC1pbF94aUM2TmxiU0lydHJpOHFvdHVvdVkwb3dEVUNrMkRQcmZQQjZORTFNTklMcm5zTFVVQUlnWQ?oc=5","date":"2021-08-19","type":"deal","source":"The Peninsula Qatar","summary":"HMC and Qatar Pharma sign deal for self-sufficiency in medical supplies - The Peninsula Qatar","headline":"HMC and Qatar Pharma sign deal for self-sufficiency in medical supplies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0AFBVV95cUxPQ3RGY0cwLUl1QzYyR1M1TWdwVjJYbUN6a0M0dmFjOEs5QU9veVU4d1VieS1WcXhmVEdQb1dpRThNekp3S1JNTWg3MUlkRm9HLWw3N1l2UWM2R3VGRVlQOVNHcHRqSTJncnFpd3lzWnhLcXd6R2hhNlRHWmNCR0JEZ0ZTT2xIZUQxbk80dGQ3aUw3Tkhtamw4WEx4SnAwUGhNcW5mMUxwTGQ2N0xFdHE0Wjgtb28tWkw3YVhTRk1QdTdKRHFEQncyUnRNQTkxcjlC?oc=5","date":"2021-08-19","type":"deal","source":"Gulf Times","summary":"Hamad Medical Corporation, Qatar Pharma Pharmaceutical Industries sign deal for medicines supply - Gulf Times","headline":"Hamad Medical Corporation, Qatar Pharma Pharmaceutical Industries sign deal for medicines supply","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxQVGsxMUtmSFdxVFMwbDZXU2dtUE13Wk1pNTFCRklvXzdiU0dOMlVWenZwUlI4REFEOGRaUmtxR19FbVE3NTFCSDE3aGZTLVNIV04wMWJoUHpBbERTTFVzWGh6dlpmZkdYdzBhTzAxYUY5bTROakpsMkthZG45MlpNWmlIY25FdHdscWtuZ3B0T0ZJUkx2TDlv?oc=5","date":"2018-02-01","type":"pipeline","source":"The Peninsula Qatar","summary":"HMC gets medicine supply from western firms - The Peninsula Qatar","headline":"HMC gets medicine supply from western firms","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxQSmVYNkc1MTAxaFVCc2NOVzZjbGsyNGxvVEZCNXRWWnBXdzgxQmJNLWFhOFZ5b2RidGdMS09Ja2FYZXhCY2ZnZGdfZFcwZHpfNTYzeVlETERrdnBIUkVpa25HLTRDN3JOZG9OU3UwV3JQejJuXzRTZWk4cHc0bVdra3ZpcC00c3FNVU9NZHVOT0QzUW5TYXc?oc=5","date":"2015-07-13","type":"pipeline","source":"Doha News | Qatar","summary":"Qatar court convicts HMC staffer & two others on bribery, forgery charges - Doha News | Qatar","headline":"Qatar court convicts HMC staffer & two others on bribery, forgery charges - Doha News | Qatar","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxQQlhqb3hhTVEyM1dZdzQtMGRGcFV2bEJDekdKZ2J2R3BDOEtZTU5lNWNHTnpBYU96ZDZfSF84N0R3aFFMZF9WTlc5aThENHMtMHhrRk1Sb2p3b3BLUG1PU1dOWmRnNWxQR2VobHJZWnpwRXZGVnhRQmpMWFozdlExbWVJMC1vdEdpbjRSa0NMd1NqOGZoWlE0LVQ0Zw?oc=5","date":"2013-02-25","type":"pipeline","source":"Pharmaceutical Technology","summary":"Sidra Medical and Research Center, Doha - Pharmaceutical Technology","headline":"Sidra Medical and Research Center, Doha","sentiment":"neutral"}],"patents":[],"drugCount":22,"phaseCounts":{"phase_3":7,"marketed":15},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}